Signaling Pathways - Sphingosine kinases (SphKs) - DOT1L - Deubiquitinating enzymes (DUBs) - c-Kit
清除全部
- B5954 Dasatinib Monohydrate中文名: 达沙替尼一水合物Target: PDGFR|c-Kit|Bcr-Abl|SrcSummary: ABL\SRC\KIT\PDGFR以及其它酪氨酸激酶抑制剂
- B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI)
- B5873 Spautin-11 CitationTarget: Deubiquitinating enzymes (DUBs)|AutophagySummary: 自噬抑制剂
- B5854 Pexidartinib (PLX3397)3 Citation中文名: 培西达替尼Target: FLT3|c-Kit|CSF1RSummary: CSF-1R抑制剂
- B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: VEGFR-2\PDGFRβ\Flt-3和c-Kit的抑制剂
- B1581 EPZ004777 HClTarget: DOT1LSummary: DOT1L抑制剂
- B1317 ML-323Target: Deubiquitinating enzymes (DUBs)Summary: USP1-UAF1抑制剂
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B2171 Imatinib (STI571)中文名: 伊马替尼Target: PDGFR|c-Kit|Bcr-AblSummary: 蛋白酪氨酸激酶抑制剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂